jim rick, are it's jim you were talking to me about how your modeling showed who is going to win. this is presidential elections better than anyone else on us. i do want to get onto. i'm again, i keep interrupting. is it so many themes in there? while i can, i've got to go to have mentioned the nuclear threats. your a big fan of charles, so i'm just p s. and the russian lieutenant colonel status of petroff. uh yes. what do you did in 1983. just explain those 2 names and as significant in the book and do all our lives. a sure i still have a few chapters on the capital markets market crash and banking panic. and we talked about the bias, but i have a chapter on the national security, but specifically about nuclear were fighting. now i started studying if we were fighting in 1969 and that was based on the works of scholars mostly done in the, in, in the 19590 in 96 is it was a albert and the roberto most other. and that's a henry kissinger, but maybe the biggest brain was harming tongue. and harmon, con no basically said, here's, here's on typically where is it gonna start? nobody's

mike shepard, with insights from democratic congressman jim himes, of connecticut and analysis from our signature panel. here on the friday edition, ricke sheehan zaino, bill burck politics contributors will be with us. we start this hour with important numbers, stronger-than-expected and certainly a bus back from last

jim. >> caller: jimmy, question for you. dvm. >> i don't know. rick moncrief just left it.. expect oil to go down 30 bucks. i say start buying stuff. i always put it in the bullpen today for my travel trust in preparation for next wednesday's meeting. i'm holding off now because oil is so weak. let's go to alma. >> caller: hi, jim. >> yo, what's going on? >> caller: long-time listener. you've helped me out so much. i appreciate it. >> thank you. >> caller: i just joined the club. >> yes. i'll see you at wednesday's meeting, 12:00. i'll tell jeff you're going to be there. the. >> caller: i'll be there. be there or be square, right? >> absolutely. >> caller: i wanted to ask you about paychex. doesn't seem like it's doing a whole lot. >> paychex reports next week. this is on hold. if the fed stops cutting rates or says, listen, we can't cut any time soon, the stock is going to fall. let's wait to see. it yields 2.7%. i like to buy the stock at 3%. that's been the right thing to do. let's employ that strategy. i need to go to nicolas in florida. nicolas. >> caller: boo-yah. wha

jim jordan waiting in the wings along with the latest on the mysterious drone story. we might have a plausible response and answer to the drones. but first up, fox news rick grif jenkins is live in west palm beach florida. very busy down there, huh? >> reporter: busy indeed. good afternoon, larry. what a contrast from the biden years. here we were back to the first trump administration with these wide ranging, anything under the sun press engagement. it went o on for about an hour d the president-elect talked about everything from the mysterious drones to the war in ukraine to the hostages in gaza to border security and the border wall and even talking about tiktok. he started his remarks standing next to japan's soft bank ceo, announcing $100 million investment that promises 1,100,000 jobs on a.i. and the like and trump noted the number of billionaires and businessmen coming this time to mar-a-lago to meet him. watch. >> b biggest difference is that people want to get along with me this time. very a lot of great executives coming in, top executives, the top bankers, they're all cal calling. >> reporter: and also at this press conference, larry, was prest

jim, meanwhile, you have meta -- >> is it deal book? >> they're not. let's get him and get dave. >> alphabet is a -- >> bezos, david ricks>> david ricks -- [ overlapping speakers ] >> speaking of lily, they say their new drug was more effective than wegovy in a head-to-head trial. the study shows that zepbound achieved a weight loss of 20%, compared to 13% for wegovy. you're talking about an extra 17 pounds. >> if only it had enough zepbound to meet the demand. i want to preface two things. wegovy's got something similar in the pipeline, but if david ricks is at deal book and talks about what i think is basically game, set, match. this reminds me so much, carl, i remember when merck came out with their drug in 1987 and everyone said merck was king. out of nowhere, warner lambert had lipitor and got caught by pfizer, and pfizer troupsed merck. could this be like wegovy, and eli lilly comes up with the equivalent of lipitor. >> the market seems to be large enough you can't say one is truly not going to -- one is going to benefit completely opposed to both. >> you're absolutely right. >> and you have amgen, which is going t